MECHANISM OF ACTION OF 1-BETA-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE (VIRAZOLE) - NEW BROAD-SPECTRUM ANTIVIRAL AGENT
MECHANISM OF ACTION OF 1-BETA-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE (VIRAZOLE) - NEW BROAD-SPECTRUM ANTIVIRAL AGENT
复制标题
DOI:
10.1073/pnas.70.4.1174
复制
发表时间:
1973-01-01
影响因子:
11.1
通讯作者:
SIMON, LN
中科院分区:
文献类型:
--
作者:
STREETER, DG;WITKOWSKI, JT;SIMON, LN
The antiviral activity of the synthetic nucleoside, Virazole (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide), against measles virus in Vero cell cultures was substantially reversed by xanthosine, guanosine, and to a slightly lesser extent by inosine. Virazole 5′-phosphate was subsequently found to be a potent competitive inhibitor of inosine 5′-phosphate dehydrogenase (IMP:NAD+oxidoreductase, EC 1.2.1.14) isolated fromEscherichia coli(Km= 1.8 × 10-5M) with aKiof 2.7 × 10-7M. Guanosine 5′-phosphate (GMP) was a competitive inhibitor of this enzyme with aKiof 7.7 × 10-5M. Virazole 5′-phosphate was similarly active against IMP dehydrogenase isolated from Ehrlich ascites tumor cells, with aKiof 2.5 × 10-7M. TheKmfor this enzyme was 1.8 × 10-5M, and theKifor GMP was 2.2 × 10-4M. These results suggest that the antiviral activity of Virazole might be due to the inhibition of GMP biosynthesis in the infected cell at the step involving the conversion of IMP to xanthosine 5′-phosphate. This inhibition would consequently result in inhibition of the synthesis of vital viral nucleic acid.